HF
IOVA icon

HRT Financial’s Iovance Biotherapeutics IOVA Stock Holding History

HRT Financial’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Sell
3,097,787
-388,512
-11% -$1.48M 0.02% 661
2026
Q1 		$12.2M Sell
3,486,299
-869,711
-20% -$2.78M 0.03% 541
2025
Q4 		$11.9M Buy
4,356,010
+3,986,314
+1,078% +$9.22M 0.04% 386
2025
Q3 		$802K Buy
369,696
+301,434
+442% +$712K ﹤0.01% 1637
2025
Q2 		$117K Sell
68,262
-292,480
-81% -$728K ﹤0.01% 2181
2025
Q1 		$1.2M Buy
+360,742
New +$1.86M 0.01% 1041
2024
Q3 		– Sell
-70,967
Closed -$569K – 2767
2024
Q2 		$569K Sell
70,967
-225,207
-76% -$2.41M ﹤0.01% 1236
2024
Q1 		$4.39M Buy
296,174
+1,411
+0.5% +$16.4K 0.03% 297
2023
Q4 		$2.4M Buy
+294,763
New +$1.54M 0.02% 572
2023
Q2 		– Sell
-267,997
Closed -$1.64M – 2841
2023
Q1 		$1.64M Buy
+267,997
New +$1.85M 0.02% 701
2022
Q4 		– Sell
-139,467
Closed -$1.34M – 2782
2022
Q3 		$1.34M Buy
+139,467
New +$1.61M 0.01% 768
2022
Q2 		– Sell
-212,974
Closed -$3.55M – 3290
2022
Q1 		$3.55M Buy
212,974
+147,460
+225% +$2.28M 0.03% 392
2021
Q4 		$1.25M Sell
65,514
-6,190
-9% -$136K 0.01% 947
2021
Q3 		$1.77M Buy
+71,704
New +$1.69M 0.01% 827
2021
Q1 		– Sell
-80,965
Closed -$3.76M – 2892
2020
Q4 		$3.76M Buy
+80,965
New +$3.21M 0.08% 193
2020
Q3 		– Sell
-112,098
Closed -$3.08M – 2113
2020
Q2 		$3.08M Buy
+112,098
New +$3.69M 0.09% 234

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

HRT Financial's IOVA Position: Q2 2026 in Review

HRT Financial reduced its Iovance Biotherapeutics (IOVA) stake by 11% in Q2 2026, selling an estimated $1.48M and leaving 3,097,787 shares worth $12.9M. The position accounts for 0.02% of the portfolio, ranked #661.

HRT Financial first reported a position in IOVA in Q2 2020 and has held it in 16 quarters since. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • HRT Financial held 3,097,787 shares of Iovance Biotherapeutics worth $12.9M as of Q2 2026.
  • HRT Financial sold 388,512 Iovance Biotherapeutics shares in Q2 2026, an estimated $1.48M.
  • Iovance Biotherapeutics made up 0.02% of HRT Financial's portfolio in Q2 2026, its #661 holding.
  • HRT Financial first reported a position in Iovance Biotherapeutics in Q2 2020 and has held it in 16 quarters since.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.